Clinical Trials Sponsored by Oscar Film

Total 172 results

Tear Film Innovations, Inc.

Completed

Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

United States
Tear Film Innovations, Inc.

Completed

Tear Film Innovations iLux Safety Study

Meibomian Gland Dysfunction | Evaporative Dry Eye

United States
Tear Film Innovations, Inc.

Completed

iLux Treatment for Meibomian Gland Dysfunction (MGD)

Evaporative Dry Eye

United States
Centre Oscar Lambret

Recruiting

Feasibility of a New Technology for Isolating Circulating Tumour Cells (CTC-SMMiL-E)

Ovarian Cancer | Hormone-resistant Prostate Cancer | Circulating Tumor Cell | HER2-positive Metastatic Breast Cancer

France
Centre Oscar Lambret

Recruiting

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) (CHIPPI)

Ovarian Cancer | Ovarian Carcinoma | Ovary Neoplasms

France, Belgium
Centre Oscar Lambret

Terminated

Mechanical Stimulation on Pain Level and Functional Discomfort After Breast Cancer Surgery

Breast Cancer

France
Centre Oscar Lambret

Completed

Impact of Peritoneal Gas Drain on Postoperative Pain for Gynaecological Cancer Patients With Minimally Invasive Surgery (DRAIN-EXSU)

Gynaecologic Cancer

France
Centre Oscar Lambret

Suspended

Phase II Study of Regorafenib as Maintenance Therapy

Metastatic Soft Tissue Sarcoma

France
Centre Oscar Lambret

Completed

Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).

Cancer

France
Centre Oscar Lambret

Completed

Feasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical Cancer (TEP-Curie)

Cervical Cancer

France
Centre Oscar Lambret

Terminated

Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility

Breast Cancer | Fertility

France
Centre Oscar Lambret

Completed

Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer (DEPOSEIN)

Breast Cancer | Leptomeningeal Metastases

France
Centre Oscar Lambret

Completed

Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects (ORACLES)

Breast Cancer

France, Monaco
Centre Oscar Lambret

Unknown

Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer (E-DIS2)

Esophageal Cancer, Squamous Cell

France
Centre Oscar Lambret

Completed

Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014

Breast Cancer

France
Centre Oscar Lambret

Completed

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (MetLung)

Non Small Cell Lung Cancer

France
Centre Oscar Lambret

Completed

Sparing of Organs at Risk in High Dose Rate Brachytherapy

Cervical Carcinoma Stage IB to IV

France
Centre Oscar Lambret

Terminated

Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer (GEMCOL)

Uterine Cervical Cancer

France
Centre Oscar Lambret

Completed

Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer (MAMMOSITE2)

Breast Cancer

France
Centre Oscar Lambret

Terminated

TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention (TSARINE)

Breast Cancer | Metastasis | Sur-expressing Her2-neu

France
Centre Oscar Lambret

Recruiting

Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) (MetroWilms)

Wilms Tumor

France
Centre Oscar Lambret

Withdrawn

Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.

Breast Cancer | Leptomeningeal Metastasis

France
Centre Oscar Lambret

Withdrawn

Alcohol and Tobacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support

Head and Neck Cancer | Lung Cancer

France
Centre Oscar Lambret

Terminated

Study of a Predictor for Cervix Cancer (ANOXICOL)

Cervix Cancer | Oncology

France
Centre Oscar Lambret

Completed

Imaging Evaluation of the Therapeutic Response of Breast Cancer Bone Metastasis (EMOS)

Breast Cancer

France
Centre Oscar Lambret

Terminated

Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma

Soft Tissue Sarcoma | Lung Metastasis

France
Centre Oscar Lambret

Completed

Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy (SPAM)

Breast Cancer

France
Centre Oscar Lambret

Completed

Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer (COLOCROSS)

Colorectal Cancer

France
Centre Oscar Lambret

Completed

Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis (CRCRT-EC)

Esophageal Cancer

France
Centre Oscar Lambret

Recruiting

Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis (Exo-LCR) (Exo-LCR)

Breast Cancer

France
Centre Oscar Lambret

Active, not recruiting

Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer (ACCRAPAN)

Cervical Cancer | Locally Advanced Cancer

France
Centre Oscar Lambret

Completed

Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on Chronic Pain of a Mastectomy (PECS)

Breastcancer | Mastectomy

France
Centre Oscar Lambret

Active, not recruiting

Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: (TOMOBREAST)

Breast Cancer

France
Centre Oscar Lambret

Active, not recruiting

Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer (KSF2)

Breast Cancer

France
Centre Oscar Lambret

Completed

Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria (ProAcTyon)

Soft Tissue Sarcoma

France
Centre Oscar Lambret

Completed

Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis (TOMOSEIN)

Breast Cancer | 2D Mammography | 3D Mammography

France
Centre Oscar Lambret

Completed

Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP).

Rectal Cancer

France
Centre Oscar Lambret

Completed

Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function (SEXUTOX)

Corpus Uteri Carcinoma

France
Centre Oscar Lambret

Terminated

Interventional Study Collecting Quantitative and Qualitative Data About Patient With Non Treated Cancer (DEREDIA)

Upper Aerodigestive Tract Cancer

France
Centre Oscar Lambret

Completed

Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel (PAL-ANGI2)

Cancer

France
Centre Oscar Lambret

Completed

Study of Stress and Life Quality of Patients Participating in Clinical Trials Versus Patients Non Participating (IPSY)

Metastatic Neoplasm | Recurrent Hematologic Cancer

France
Centre Oscar Lambret

Completed

Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma (CILENT-0902)

Diffuse Intrinsic Pontine Glioma

France
Centre Oscar Lambret

Completed

Sentinel Lymph Node Technique in Multifocal Breast Cancer

Breast Cancer

France
Centre Oscar Lambret

Unknown

Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer

Epidermoid Head and Neck Cancer

France
Centre Oscar Lambret

Completed

Breast Cancer and Quality of Life (KALICOU)

Breast Cancer

France
Centre Oscar Lambret

Terminated

Excision Limits of Oral Cavity Tumor by Narrow Band Imaging

Cancer

France
Centre Oscar Lambret

Completed

Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer (PALANGI-0601)

Cancer

France
Centre Oscar Lambret

Completed

Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports (CCI)

Cancer

France
Centre Oscar Lambret

Completed

Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases (TKI-CPK-1003)

Cancer | Solid Tumor

France
Centre Oscar Lambret

Completed

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate (PALANGI3)

Cancer

France

3

Subscribe